RxDoctor Payments Data

Parvin Peddi

Internal Medicine · San Francisco, CANPI 1447346390

Payments from drug & device makers

$498,002in general payments, 2019–2025

Across 30 payments — averaging $16,600 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$284K
  • Novartis$143K
  • Sanofi US Services Inc.$70K
  • Merck$81
  • Lilly USA, LLC$65
  • Daiichi Sankyo Inc.$55
  • plus $92 from 4 others
$462in research payments, 2019–2025

Across 1 payment — averaging $461.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$462

What the payments were for

  • Food & beverage$293100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$498,002 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Other internal medicine in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →